GLENMARK PHARMACEUTICALS LTD. - Clarifies on News item

	< Back
29 Dec 2014
With reference to the news item appearing in the financial daily titled "Glenmark to out-license molecule for pain management", Glenmark Pharmaceuticals Ltd has Clarified to BSE as under"<BR><BR>"As a part of its business, the Company enters into discussions with various Pharmaceutical Companies (Interested licensees) with respect to its innovative product pipeline. Such discussions are mostly exploratory and may or may not result in a business deal.<BR><BR>We confirm that at present there are no negotiations taking place.<BR><BR>In the circumstances, we submit that this news item does not require disclosure under Clause 36 of the Listing agreement."
View all announcements for GLENMARK PHARMACEUTICALS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us